Travis Steed
BofA Securities, Research Division

Next up, we have Edwards Life Sciences. Welcome, Bernard.

Bernard Zovighian
CEO & Director

Thank you.

Travis Steed
BofA Securities, Research Division

Thanks for coming.

Bernard Zovighian
CEO & Director

How are you doing?

Travis Steed
BofA Securities, Research Division

Good.

Bernard Zovighian
CEO & Director

Excellent. Good to be here. Hi, everyone.

Travis Steed
BofA Securities, Research Division

Maybe I'll let you open. I know you want to make some opening remarks to get started. Let's just go and that?

Bernard Zovighian
CEO & Director

Yes. No, thanks. So look, it is -- we feel good about where we are at as a company. And when I step back and reflect the reason why, I think we have a great deal of strategy. We have a strategic clarity. This is all about structural heart. Everybody in the company is focusing on that. We have a great culture. We -- the employees, about 16,000 are fully engaged, inspired by our patient-focused culture. Execution is amazing across the other company. And sale of Critical Care a couple of years ago help us even further to be very agile, fast execution, and you have seen that. And all of this is resulting in my mind, a very differentiated performance, but also sustainable performance. We had a great year last year. Q1 was the same growing double digit. But also it is less about double digit, more about broad-based across surgical TAVR, mitral and tricuspid. Also broad across regions. So this is what gives us confidence. It is sustainable. People are behind us. Strategic clarity and great execution. So feeling good about the year ahead of us.